Case: Molluscum contagiosum: Toxic shock syndrome following cantharidin treatment

Canadian Family Physician

Volumn 49, Issue JULY, 2003, Pages 887-889

  Langley, Joanne M ^a,b   Soder, C M ^b   Schlievert, P M ^c   Murray, S ^b  

^a IWK HEALTH CENTRE   (Canada)

^b UNIVERSITY OF MINNESOTA   (United States)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANTHARIDIN; CATHARONE; CEFOTAXIME; CLINDAMYCIN; CLOXACILLIN; SALICYLIC ACID; TOXIC SHOCK SYNDROME TOXIN 1; VANCOMYCIN; IRRITANT AGENT;

ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; DIARRHEA; DOSE RESPONSE; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; FEVER; HUMAN; LABORATORY TEST; MALE; MOLLUSCUM CONTAGIOSUM; PHYSICAL EXAMINATION; PRESCHOOL CHILD; TOXIC SHOCK SYNDROME; UNCONSCIOUSNESS; VOMITING; CHEMICALLY INDUCED DISORDER; ISOLATION AND PURIFICATION; PATHOGENICITY; PROTECTIVE CLOTHING; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CANTHARIDIN; CHILD, PRESCHOOL; HUMANS; IRRITANTS; MALE; MOLLUSCUM CONTAGIOSUM; OCCLUSIVE DRESSINGS; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0037704834     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Silverman RA. Office-based treatment of pediatric skin disease. Pediatr Clin North Am 2000;47:859-65.
2. Ordoukhanian E, Lane AT. Warts and molluscum contagiosum: beware of treatments worse than the disease. Postgrad Med 1997;101:223-6, 229-32, 235.
3. American Academy of Pediatrics. Toxic shock syndrome. In: Pickering L, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, Ill: American Academy of Pediatrics; 2000. p. 576-81.
4. Epstein E. Cantharidin therapy for molluscum contagiosum in children. J Am Acad Dermatol 2001;45:638.
5. Schlievert PM, Blomster DA. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis 1983;147:236-42.
6. Eldridge R, Casida JE. Cantharidin effects on protein phosphatases and the phosphorylation state of phosphoproteins in mice. Toxicol Appl Pharmacol 1995;130:95-100.
7. Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I staphylococci. Lancet 1978;2:1116-8.
8. Hajjeh RA, Reingold A, Weil A, Shutt K, Schuchat A, Perkins BA. Toxic shock syndrome in the United States: surveillance update, 1979 1996. Emerg Infect Dis 1999;5:807-10.
9. McCormick JK, Yarwood JM, Schlievert PM. Toxic shock syndrome and bacterial superantigens: an update. Ann Rev Microbiol 2001;55:77-104.
10. Schlievert PM, Kelly JA. Clindamycin-induced suppression of toxic-shock syndrome-associated exotoxin production. J Infect Dis 1984;149:471.